Discontinuation report GLUCONORM 0.5MG
| Report ID | 201483 |
| Drug Identification Number | 02239924 |
| Brand name | GLUCONORM 0.5MG |
| Common or Proper name | Gluconorm 0.5MG |
| Company Name | NOVO NORDISK CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | REPAGLINIDE |
| Strength(s) | 0.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 90 |
| ATC code | A10BX |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2024-02-28 |
| Actual discontinuation date | 2024-02-28 |
| Remaining supply date | 2024-02-28 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 101-2476 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 6M1 |
| Company contact information | 1 800 465 4334 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-03-04 | French | Compare |
| v5 | 2024-03-04 | English | Compare |
| v4 | 2023-08-09 | French | Compare |
| v3 | 2023-08-09 | English | Compare |
| v2 | 2023-08-09 | French | Compare |
| v1 | 2023-08-09 | English | Compare |
Showing 1 to 6 of 6